117 related articles for article (PubMed ID: 9849480)
21. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
[TBL] [Abstract][Full Text] [Related]
22. Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia.
Wong JM; Liu D; Lurain JR
J Reprod Med; 2014; 59(5-6):204-8. PubMed ID: 24937958
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of trophoblastic disease].
Semenovskiĭ AV
Vopr Onkol; 1974; 20(2):93-106. PubMed ID: 4140612
[No Abstract] [Full Text] [Related]
24. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Xue Y; Zhang J; Wu TX; An RF
Cochrane Database Syst Rev; 2006 Jul; (3):CD005196. PubMed ID: 16856085
[TBL] [Abstract][Full Text] [Related]
25. Update in cancer chemotherapy: genitourinary tract cancer, Part 7: Gestational trophoblastic neoplasms.
Wright JC
J Natl Med Assoc; 1988 Jul; 80(7):753-61. PubMed ID: 2841462
[TBL] [Abstract][Full Text] [Related]
26. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
Verhoef L; Baartz D; Morrison S; Sanday K; Garrett AJ
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):458-463. PubMed ID: 28345753
[TBL] [Abstract][Full Text] [Related]
28. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
29. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
30. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
32. Gestational trophoblastic disease.
Berkowitz RS; Goldstein DP
Cancer; 1995 Nov; 76(10 Suppl):2079-85. PubMed ID: 8635004
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Deng L; Yan X; Zhang J; Wu T
Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618
[TBL] [Abstract][Full Text] [Related]
34. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
35. Reproductive performance of women successfully treated for gestational trophoblastic tumors.
Walden PA; Bagshawe KD
Am J Obstet Gynecol; 1976 Aug; 125(8):1108-14. PubMed ID: 181990
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients.
Lan Z; Hongzhao S; Xiuyu Y; Yang X
Gynecol Oncol; 2001 Oct; 83(1):146-8. PubMed ID: 11585428
[TBL] [Abstract][Full Text] [Related]
37. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
Khoo SK; Jones IS
Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
[TBL] [Abstract][Full Text] [Related]
38. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
39. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms.
Hammond CB; Hertz R; Ross GT; Lipsett MB; Odell WD
Am J Obstet Gynecol; 1967 May; 98(1):71-8. PubMed ID: 4290287
[No Abstract] [Full Text] [Related]
40. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
